| Tocilizumab in patients with severe COVID-19: a retrospective cohort study G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ... The Lancet Rheumatology 2 (8), e474-e484, 2020 | 1089 | 2020 |
| Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020 | 738 | 2020 |
| The effect of pathophysiology on pharmacokinetics in the critically ill patient—concepts appraised by the example of antimicrobial agents SI Blot, F Pea, J Lipman Advanced drug delivery reviews 77, 3-11, 2014 | 520 | 2014 |
| Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability F Pea, P Viale, M Furlanut Clinical pharmacokinetics 44, 1009-1034, 2005 | 435 | 2005 |
| The clinical relevance of plasma protein binding changes JA Roberts, F Pea, J Lipman Clinical pharmacokinetics 52, 1-8, 2013 | 367 | 2013 |
| Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats L Benedetti, R Cortivo, T Berti, A Berti, F Pea, M Mazzo, M Moras, ... Biomaterials 14 (15), 1154-1160, 1993 | 289 | 1993 |
| Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy F Pea, P Viale, F Pavan, M Furlanut Clinical pharmacokinetics 46, 997-1038, 2007 | 264 | 2007 |
| Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients F Pea, P Viale, P Cojutti, B Del Pin, E Zamparini, M Furlanut Journal of antimicrobial chemotherapy 67 (8), 2034-2042, 2012 | 263 | 2012 |
| An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units G Wong, A Brinkman, RJ Benefield, M Carlier, JJ De Waele, N El Helali, ... Journal of antimicrobial chemotherapy 69 (5), 1416-1423, 2014 | 253 | 2014 |
| Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock–does the dose matter? F Pea, P Viale Critical Care 13 (3), 214, 2009 | 250 | 2009 |
| Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis MA Cataldo, E Tacconelli, E Grilli, F Pea, N Petrosillo Journal of antimicrobial chemotherapy 67 (1), 17-24, 2012 | 238 | 2012 |
| Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis F Pea, M Furlanut, P Cojutti, F Cristini, E Zamparini, L Franceschi, P Viale Antimicrobial agents and chemotherapy 54 (11), 4605-4610, 2010 | 224 | 2010 |
| Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose F Pea, L Brollo, P Viale, F Pavan, M Furlanut Journal of Antimicrobial Chemotherapy 51 (4), 971-975, 2003 | 211 | 2003 |
| Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions F Pea, M Furlanut Clinical pharmacokinetics 40, 833-868, 2001 | 199 | 2001 |
| Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses M Arlotti, P Grossi, F Pea, G Tomei, V Vullo, FG De Rosa, G Di Perri, ... International Journal of Infectious Diseases 14, S79-S92, 2010 | 187 | 2010 |
| The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill … LD Saravolatz, F Pea, P Viale Clinical infectious diseases 42 (12), 1764-1771, 2006 | 163 | 2006 |
| Challenges in the management of chronic wound infections M Falcone, B De Angelis, F Pea, A Scalise, S Stefani, R Tasinato, ... Journal of global antimicrobial resistance 26, 140-147, 2021 | 154 | 2021 |
| Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients F Pea, M Furlanut, C Negri, F Pavan, M Crapis, F Cristini, P Viale Antimicrobial agents and chemotherapy 53 (5), 1863-1867, 2009 | 154 | 2009 |
| Ceftolozane/tazobactam: place in therapy DR Giacobbe, M Bassetti, FG De Rosa, V Del Bono, PA Grossi, ... Expert review of anti-infective therapy 16 (4), 307-320, 2018 | 135 | 2018 |
| WSES consensus conference: Guidelines for first-line management of intra-abdominal infections M Sartelli, P Viale, K Koike, F Pea, F Tumietto, H van Goor, G Guercioni, ... World Journal of Emergency Surgery 6, 1-29, 2011 | 128 | 2011 |
